通过虚拟查,基于人工智能的预测和分子动力学,用于FAK激活的新型化合物的in silico发现
1Department of Physiology, School of Medicine, Pusan National University, Yangsan, 50612, Republic of Korea.
Computational biology and chemistry
|March 29, 2025
概括
研究人员确定了新型化合物来增强焦点粘附激酶 (FAK) 活性,这是癌症的关键目标. 使用人工智能和虚拟查,他们确定了三个有前途的药物候选人进行进一步研究.
科学领域:
- 生物化学和分子生物学
- 计算化学和药物发现
背景情况:
- 焦点粘附激酶 (FAK) 是一种关键的非受体氨酸激酶,参与细胞信号传递,增殖和迁移.
- 过度表达FAK与转移性和晚期癌症有关,但其活性在其他疾病中可能会下降.
- 需要能够调节FAK活性的化合物,特别是在疾病背景下增强FAK活性.
研究的目的:
- 确定能够增强焦点粘附激酶 (FAK) 活性的新型化合物.
- 为药物发现利用基于结构的虚拟查和人工智能 (AI).
- 选一个大型的化学数据库,寻找潜在的FAK活性增强剂.
主要方法:
- 利用基于结构的虚拟选管道在超过1000万个化合物的数据库上.
- 采用Tanimoto相似性来识别与已知FAK激活剂 (ZINC40099027) 结构相关的化合物.
- 应用K-means集群,分子对接,深度学习 (GLAM用于BBB透性,elEmBERT用于毒性),SAScorer和50 ns分子动力学 (MD) 模拟用于化合物评估.
主要成果:
- 选了超过1000万种化合物,根据相似性,对接,AI预测和物理化学特性确定了10个有前途的候选物.
- 进行了MD模拟,以评估前10个化合物与FAK相互作用的稳定性.
- 在严格的in silico评估后,确定了前三大最有前途的候选化合物.
结论:
- 该研究成功地确定了三种新型化合物,这些化合物有可能增强FAK活性.
- 结合虚拟查,人工智能和分子动态的综合方法对于发现潜在的候选药物是有效的.
- 这些已识别的化合物需要进一步的实验验证,以便用于治疗开发.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
3.2K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.0K
相关概念视频
01:26Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
01:28Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K